Trials / Completed
CompletedNCT01781169
Vitamin D Supplementation to Obese Chinese Males
Health Effect of Oral Vitamin D Supplementation on Obese Chinese Males
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 43 (actual)
- Sponsor
- Shenzhen Center for Chronic Disease Control · Academic / Other
- Sex
- Male
- Age
- 23 Years – 66 Years
- Healthy volunteers
- Accepted
Summary
Hypothesis: Oral Supplementation of Vitamin D can Reduce Hypersecretion of Parathyroid Hormone and Insulin Resistance in Obese Chinese Males. Protocol: Weekly oral supplementation of 50,000 IU vitamin D (cholecalciferol) or eight weeks to the obese males compared with the normal-weight males. Index measures were conducted at baseline and endpoint.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Oral supplementation of vitamin D | Weekly oral supplementation of 50,000 IU vitamin D (cholecalciferol) for eight weeks to the obese males compared with the normal-weight males. The chemical form of vitamin D is cholecalciferol capsuled as fine powder. |
Timeline
- Start date
- 2011-04-01
- Primary completion
- 2011-12-01
- Completion
- 2012-12-01
- First posted
- 2013-01-31
- Last updated
- 2013-10-30
- Results posted
- 2013-09-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT01781169. Inclusion in this directory is not an endorsement.